Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    World neurosurgery · 2022
    RSRajiv S. Magge
    PMID: 36192862DOISenior author11 citations
  2. 2
    Journal of immunotherapy (Hagerstown, Md. : 1997) · 2022
    KVKoen Van BesienBLBenjamin LiechtyRSRajiv S. Magge
    PMID: 35404315PMCID: PMC13215045DOISenior author13 citations
  3. 3
    World neurosurgery · 2021
    RSRajiv S. MaggeHAHoward Alan Fine
    PMID: 34243672DOIFirst author8 citations

Publications

65 publications

Funding

2 grants

Active

1 grant
  • Co-I
    Dual-[Hypoxia+Proliferation] PET as a Predictive Biomarker in Recurrent Glioblastoma
    National Cancer Institute · 2026–2031
    R01CA308323-01A1
Completed grants (1)
  • Co-I
    Machine Learning Approaches to Improve Histological Interpretation of Glioblastoma
    William Rhodes Center for Glioblastoma - Collaborative Research Initiative · 2020–2021
    WRCG 210432-01

Clinical research

3 studies
Completed & closed trials (3)
  • PI
    A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
    PHASE2; PHASE3 · NRG Oncology · IRB STUDY CLOSURE (as of 2026)
    Gliosarcoma; MGMT-Unmethylated Glioblastoma
    NCT04396860
  • PI
    Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
    PHASE2 · Alliance for Clinical Trials in Oncology · CLOSED TO ACCRUAL (as of 2023)
    Intracranial Meningioma; Recurrent Meningioma; NF2 Gene Mutation
    NCT02523014
  • PI
    Genomically-Guided Treatment Trial in Brain Metastases
    PHASE2 · Alliance for Clinical Trials in Oncology
    CDK Gene Mutation; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Solid Neoplasm; NTRK Family Gene Mutation; PI3K Gene Mutation; ROS1 Gene Mutation; KRAS G12C Mutation
    NCT03994796